BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11462067)

  • 21. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer.
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K
    Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic invasion is a more significant prognostic factor than visceral pleural invasion in non-small cell lung cancer with tumours of 3 cm or less.
    Moon Y; Park JK; Lee KY; Sung SW
    Respirology; 2017 Aug; 22(6):1179-1184. PubMed ID: 28382791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of peripheral blood T lymphocyte surface activation markers and transcription factors in patients with early stage non-small cell lung cancer.
    Rutkowski J; Cyman M; Ślebioda T; Bemben K; Rutkowska A; Gruchała M; Kmieć Z; Pliszka A; Zaucha R
    Cell Immunol; 2017 Dec; 322():26-33. PubMed ID: 28939130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing PDL-1 and PD-1 in Non-Small Cell Lung Cancer: A Novel Immunoscore Approach.
    Paulsen EE; Kilvaer TK; Khanehkenari MR; Al-Saad S; Hald SM; Andersen S; Richardsen E; Ness N; Busund LT; Bremnes RM; Donnem T
    Clin Lung Cancer; 2017 Mar; 18(2):220-233.e8. PubMed ID: 27816392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement component 3 is a prognostic factor of non‑small cell lung cancer.
    Lin K; He S; He L; Chen J; Cheng X; Zhang G; Zhu B
    Mol Med Rep; 2014 Aug; 10(2):811-7. PubMed ID: 24819254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan.
    Koike T; Tsuchiya R; Goya T; Sohara Y; Miyaoka E
    J Thorac Oncol; 2007 May; 2(5):408-13. PubMed ID: 17473656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of White Blood Cells Detected for the First Time After Adjuvant Chemotherapy in Primary Operable Non-Small Cell Lung Cancer.
    Hao L; Zhang J; Di Y; Tan Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802813. PubMed ID: 30295143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis.
    Lim E; Clough R; Goldstraw P; Edmonds L; Aokage K; Yoshida J; Nagai K; Shintani Y; Ohta M; Okumura M; Iwasaki T; Yasumitsu T; Okada M; Mimura T; Tsubota N; Nakagawa T; Okumura N; Satoh Y; Okumura S; Nakagawa K; Higashiyama M; Kodama K; Riquet M; Vicidomini G; Santini M; Kotoulas C; Hsu JY; Chen CY;
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1441-6. PubMed ID: 19939412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer.
    Lim E; Ali A; Theodorou P; Nicholson AG; Ladas G; Goldstraw P
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1113-8. PubMed ID: 15052210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-Presenting Intratumoral B Cells Affect CD4
    Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
    Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer?
    Vicidomini G; Santini M; Fiorello A; Parascandolo V; Calabrò B; Pastore V
    Ann Thorac Surg; 2005 Jan; 79(1):254-7; discussion 254-7. PubMed ID: 15620952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer.
    Guo D; Zhang J; Jing W; Liu J; Zhu H; Fu L; Li M; Kong L; Yue J; Yu J
    Future Oncol; 2018 Oct; 14(25):2643-2650. PubMed ID: 29747545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of pleural lavage cytology examined during surgery for primary lung cancer.
    Kaneda M; Yokoi K; Ito S; Niwa H; Takao M; Kondo R; Arimura T; Saito Y
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1335-41. PubMed ID: 22223692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoembryonic antigen level in serum and pleural lavage fluid in non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Yonei A; Onitsuka T
    Thorac Cardiovasc Surg; 2010 Sep; 58(6):350-3. PubMed ID: 20824588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.